Equities

Accelerate Diagnostics Inc

Accelerate Diagnostics Inc

Actions
  • Price (USD)1.54
  • Today's Change1.54 / --
  • Shares traded982.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Sep 09 2024 16:34 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments134664
Total Receivables, Net2.622.422.32
Total Inventory3.315.195.07
Prepaid expenses0.380.820.77
Other current assets, total4.942.031.56
Total current assets245673
Property, plant & equipment, net5.087.767.90
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets1.821.241.82
Total assets316583
LIABILITIES
Accounts payable4.804.501.98
Accrued expenses4.383.984.43
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.31580.08
Other current liabilities, total1.550.550.45
Total current liabilities12676.95
Total long term debt3618108
Total debt3875108
Deferred income tax------
Minority interest------
Other liabilities, total2.863.083.19
Total liabilities5187118
SHAREHOLDERS EQUITY
Common stock0.010.100.07
Additional paid-in capital695630581
Retained earnings (accumulated deficit)(669)(607)(571)
Treasury stock - common(45)(45)(45)
Unrealized gain (loss)------
Other equity, total(0.61)(0.4)(0.06)
Total equity(20)(22)(35)
Total liabilities & shareholders' equity316583
Total common shares outstanding159.756.76
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.